The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ma Isabel Lucena

Clincal Pharmacology Service

School of Medicine

University Hospital Virgen de la Victoria

Málaga

Spain

[email]@uma.es

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Clincal Pharmacology Service, School of Medicine, University Hospital Virgen de la Victoria, Málaga, Spain. 2009
  • Servicio de Farmacología Clínica, Hospital Universitario Virgen de Victoria, School of Medicine, Málaga, Spain. 2000 - 2009
  • Servicio de Farmacología Clínica, Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Coordinating Centre, Hospital Universitario Virgen de la Victoria, Spain. 2006
  • Department of Clinical Pharmacology, Facultad de Medicina, E-29071-Malaga, Spain. 2006

References

  1. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Lucena, M.I., Andrade, R.J., Kaplowitz, N., García-Cortes, M., Fernández, M.C., Romero-Gomez, M., Bruguera, M., Hallal, H., Robles-Diaz, M., Rodriguez-González, J.F., Navarro, J.M., Salmeron, J., Martinez-Odriozola, P., Pérez-Alvarez, R., Borraz, Y., Hidalgo, R. Hepatology (2009) [Pubmed]
  2. Assessment of drug-induced liver injury in clinical practice. Lucena, M.I., García-Cortés, M., Cueto, R., Lopez-Duran, J., Andrade, R.J. Fundam. Clin. Pharmacol (2008) [Pubmed]
  3. Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Lucena, M.I., Andrade, R.J., Martínez, C., Ulzurrun, E., García-Martín, E., Borraz, Y., Fernández, M.C., Romero-Gomez, M., Castiella, A., Planas, R., Costa, J., Anzola, S., Agúndez, J.A. Hepatology (2008) [Pubmed]
  4. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Lucena, M.I., Andrade, R.J., Fernández, M.C., Pachkoria, K., Pelaez, G., Durán, J.A., Villar, M., Rodrigo, L., Romero-Gomez, M., Planas, R., Barriocanal, A., Costa, J., Guarner, C., Blanco, S., Navarro, J.M., Pons, F., Castiella, A., Avila, S. Hepatology (2006) [Pubmed]
  5. Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report. Lucena, M.I., Andrade, R.J., Vicioso, L., González, F.J., Pachkoria, K., García-Muñoz, B. World J. Gastroenterol. (2006) [Pubmed]
  6. The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment. Lucena, M.I., López-Torres, E., Verge, C., Andrade, R.J., Puche, M.J., Seoane, J., de la Cuesta, F.S. Eur. J. Gastroenterol. Hepatol (2005) [Pubmed]
  7. Drug use for non-hepatic associated conditions in patients with liver cirrhosis. Lucena, M.I., Andrade, R.J., Tognoni, G., Hidalgo, R., Sanchez de la Cuesta, F. Eur. J. Clin. Pharmacol. (2003) [Pubmed]
  8. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study. Lucena, M.I., Andrade, R.J., de la Cruz, J.P., Rodriguez-Mendizabal, M., Blanco, E., Sánchez de la Cuesta, F. Int. J. Clin. Pharmacol. Ther (2002) [Pubmed]
  9. Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis. Lucena, M.I., Andrade, R.J., Tognoni, G., Hidalgo, R., De La Cuesta, F.S. Eur. J. Clin. Pharmacol. (2002) [Pubmed]
  10. Comparison of two clinical scales for causality assessment in hepatotoxicity. Lucena, M.I., Camargo, R., Andrade, R.J., Perez-Sanchez, C.J., Sanchez De La Cuesta, F. Hepatology (2001) [Pubmed]
  11. Trovafloxacin-induced acute hepatitis. Lucena, M.I., Andrade, R.J., Rodrigo, L., Salmerón, J., Alvarez, A., Lopez-Garrido, M.J., Camargo, R., Alcantára, R. Clin. Infect. Dis. (2000) [Pubmed]
 
WikiGenes - Universities